About: Lakewood-Amedex Biotherapeutics, Inc. operates as a clinical-stage biotechnology company that develops antimicrobial products in the United States. The company offers products from its Bisphosphocin class, a novel class of antimicrobial agents a broad range of infections, including those affecting the skin, bladder, and lungs. It also develops Nu-3, a topical antimicrobial for infected diabetic foot ulcers, which is in Phase 2b clinical trial. The company was formerly known as Lakewood-Amedex Inc. and changed its name to Lakewood-Amedex Biotherapeutics, Inc. in June 2025. Lakewood-Amedex Biotherapeutics, Inc. was incorporated in 2006 and is headquartered in University Park, Florida.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.47 (+1.52%)
LABT NASDAQ Lakewood-Amedex Biotherapeutics Inc. Common Stock
Lakewood-Amedex Biotherapeutics Inc. Common Stock share price
Atividade de preço de LABT
Último preço
$ 0,470
Variação (24h)
0,01 USD (1,52%)
Volume
246.56K
Volume (média 4 sem.)
-
Abertura
$ 0,47
Variação do dia
$ 0,46 - $ 0,51
Fechamento anterior
$ 0,47
Último negócio
22 Oct, 4:23 pm GMT+0
Atrasado
22 Oct, 4:23 pm GMT+0
LABT price performance
Atrasado
22 Oct, 4:23 pm GMT+0
quote.marketSignals